[Treatment of rheumatoid arthritis].
D000311:Adrenal Glands / Q000503:physiopathology; D000309:Adrenal Insufficiency / Q000150:complications; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000962:Antimalarials / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D004700:Endocrine System Diseases / Q000150:complications; D005938:Glucocorticoids / Q000627:therapeutic use; D006046:Gold / Q000627:therapeutic use; D006801:Humans; D007018:Hypopituitarism / Q000150:complications; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007239:Infections / Q000150:complications; D008797:Metyrapone / Q000627:therapeutic use; D009989:Orthotic Devices; D026741:Physical Therapy Modalities; D010902:Pituitary Gland / Q000503:physiopathology; D010907:Pituitary Hormones / Q000627:therapeutic use; D011720:Pyrazoles / Q000627:therapeutic use; D012459:Salicylates / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000962:Antimalarials; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D010907:Pituitary Hormones; D011720:Pyrazoles; D012459:Salicylates; D006046:Gold; D008797:Metyrapone
In tema di trattamento dell'artrite reumatoide